Home » Newsletters » BioWorld Science

BioWorld Science

March 20, 2012

View Archived Issues

Sangamo cell therapy increases CD4+ T-cell counts in patients with HIV

Novacta Biosystems develops novel candidate antibacterials

Phase I trial assesses interaction between diabetes therapies

Novel first-in-human data presented on Medimmune cancer immunotherapy

New data highlight role of lymphopoietin in chronic rhinosinusitis with nasal polyps

U.S. study links SNPs to complications after subarachnoid hemorrhage

Cartagenia enters partnership for rare epilepsy syndromes

Merck & Co. enters into collaboration to create new institute

Ampio provides update on Optina trial

Once-daily tramadol capsule launched in Canada for chronic pain

Alnylam launches phase I trial of transthyretin-mediated amyloidosis therapy

Provectus Pharmaceuticals reports topline phase II data on PH-10

QRxPharma and Actavis sign new licensing agreement

CUNY to validate diagnostic antibodies

Novel GPR124 receptor agonists designed in U.S.

New potential flu therapies presented

New nicotinic acetylcholine receptor ligands synthesized

Boehringer Ingelheim Pharma divulges new MPGES-1 inhibitors

Santhera reports novel mitochondrial function modulators

Avaxia receives second NIH grant for oral IBD immunotherapeutic

Merck & Co. to discontinue development of vernakalant formulation

AstraZeneca and Targacept give update on TC-5214 development

First once-daily 24-hour LABA for COPD maintenance launched in U.S.

Enrollment complete in phase III trials of allergy immunotherapy

Cellceutix enters collaboration agreement to support Kevetrin development

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...